Welcome to our dedicated page for NUCOR SEC filings (Ticker: NUE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on NUCOR's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into NUCOR's regulatory disclosures and financial reporting.
Nucor Corporation (NUE) has filed an automatic shelf registration statement on Form S-3 as a well-known seasoned issuer, allowing it to offer from time to time debt securities, common stock and preferred stock, together or separately. These securities may be sold through underwriters, dealers, agents, directly to investors, or in “at the market” offerings.
The debt securities will be Nucor’s senior unsecured obligations, ranking equally with its other senior unsecured debt and being structurally subordinated to liabilities of its subsidiaries. The common stock is listed on the New York Stock Exchange under the symbol “NUE”. As of July 4, 2026, 226,875,676 shares of common stock were issued and outstanding. Nucor is authorized to issue 800,000,000 shares of common stock and 250,000 shares of preferred stock, of which none are outstanding.
Unless specified otherwise in a prospectus supplement, net proceeds from future offerings will be used for general corporate purposes, including working capital, capital expenditures, investments in subsidiaries, acquisitions, debt repayment and stock repurchases, with temporary investment in short-term instruments pending use.
NUCOR CORP (NUE) reported insider transactions by Chair and CEO Leon J. Topalian. On August 14, 2026 he exercised 26,000 stock options for common shares at an exercise price of $42.46 per share, leaving 145,981 options outstanding. That same day he sold 25,898 shares at a weighted average price of $268.518 and 102 shares at a weighted average price of $269.29, each across multiple trades within stated price ranges. On August 17, 2026 he made a bona fide gift of 1,800 shares of common stock. As of August 14, 2026 he also held 1,357.03 indirect shares through the Nucor Profit Sharing Plan, representing a Nucor Stock Fund balance of $364,917.61.
NUCOR CORP (NUE) executive vice president Allen C. Behr reported option exercises and share sales. On 2026-08-14 he exercised an employee stock option for 7,739 shares of common stock at an exercise price of $110.74 per share, eliminating that option position. He then sold 5,127 shares at a weighted average price of $274.0012 (individual trades ranged from $273.365 to $274.255) and 2,612 shares at a weighted average price of $274.4156 (trades ranged from $274.410 to $274.450). The Rule 10b5‑1 plan checkbox was not marked as being used for these transactions.
An affiliate of NUE has filed a notice of proposed resale of 26,000 shares of common stock through Fidelity Brokerage Services LLC, with an aggregate market value of $6,981,555.03, in connection with a stock option exercise expected on 08/14/2026. The filing also reports that Leon Topalian sold 52,000 shares of common stock on 05/15/2026 over the past three months for total proceeds of $11,839,781.20.
Nucor Corporation reported substantially higher results for the quarter ended July 4, 2026. Net sales rose to $10.40 billion from $8.46 billion a year earlier, while net earnings attributable to stockholders increased to $1.16 billion from $603 million. Diluted earnings per share were $5.04, up from $2.60. For the first six months of 2026, net sales were $19.89 billion and net earnings attributable to stockholders were $1.90 billion.
Operating cash flow for the first six months improved to $2.29 billion from $1.10 billion, funding capital expenditures of $1.23 billion and share repurchases of $475 million, plus $258 million of cash dividends. Total assets were $36.95 billion and total equity $23.27 billion as of July 4, 2026. The board authorized a new $4.00 billion share repurchase program, with approximately $3.62 billion still available.
Nucor Corp Executive Vice President Thomas J. Batterbee reported selling 4000.0000 shares of Nucor common stock on 2026-08-03 in a sale described as an open market or private transaction at an average price of 261.0156 per share, leaving him with 16137.8700 shares held directly.
Nucor Corporation (NUE) reports a planned sale of 4,000 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate value of $1,044,062.40 and a proposed sale date of August 3, 2026. The filing also lists prior share acquisitions from restricted stock vesting on June 1, 2024, March 10, 2025, and June 1, 2026 as compensation awards.
Stephen D. Laxton, President and COO of Nucor Corp, reported two transactions in Nucor common stock dated 2026-07-30. He made a bona fide gift of 2,409 shares and separately sold 3,968 shares of common stock at $256.96 per share in an open market or private transaction.